Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective binding to enzyme targets, making it valuable in medicinal chemistry research. Commonly employed in the preparation of small-molecule drug candidates targeting tyrosine kinases and other signaling proteins involved in tumor growth. Also utilized in structure-activity relationship (SAR) studies to optimize potency and selectivity of new therapeutic agents.